Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-04-018553
Filing Date
2004-04-01
Accepted
2004-04-01 15:24:47
Documents
1
Period of Report
2004-01-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 OF RICHARD J. HINDIN (JANUARY 23, 2004) rrd38334.html 4  
1 FORM 4 OF RICHARD J. HINDIN (JANUARY 23, 2004) rrd38334.xml 4 10654
  Complete submission text file 0001181431-04-018553.txt   12593
Mailing Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 3019611992
REGENERX BIOPHARMACEUTICALS INC (Issuer) CIK: 0000707511 (see all company filings)

EIN.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address ALPHA 1 BIOMEDICALS INC 3 BETHESDA METRO CENTER BETHSEDA MD 20814 3019611992
HINDIN RICHARD J (Reporting) CIK: 0001125613 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-15070 | Film No.: 04709394